UK markets closed

ImmunoPrecise Antibodies Ltd. (IPA)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.8600+0.0170 (+2.02%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Apr 2024)Next qtr. (Jul 2024)Current year (2024)Next year (2025)
No. of analysts2121
Avg. Estimate-0.08-0.07-0.34-0.25
Low estimate-0.09-0.07-0.35-0.25
High estimate-0.07-0.07-0.33-0.25
Year ago EPS-0.16-0.1-0.79-0.34
Revenue estimateCurrent qtr. (Apr 2024)Next qtr. (Jul 2024)Current year (2024)Next year (2025)
No. of analysts2121
Avg. Estimate4.72M4.92M17.79M21.57M
Low estimate4.63M4.92M17.7M21.57M
High estimate4.82M4.92M17.89M21.57M
Year ago sales4.11M3.92M15.19M17.79M
Sales growth (year/est)14.90%25.50%17.10%21.20%
Earnings history29/04/202330/07/202330/10/202330/01/2024
Est. EPS-0.13-0.15-0.1-0.07
Actual EPS-0.16-0.1-0.07-0.08
Difference-0.030.050.03-0.01
Surprise %-23.10%33.30%30.00%-14.30%
EPS trendCurrent qtr. (Apr 2024)Next qtr. (Jul 2024)Current year (2024)Next year (2025)
Current estimate-0.08-0.07-0.34-0.25
7 days ago-0.08-0.07-0.35-0.26
30 days ago-0.08-0.07-0.35-0.26
60 days ago-0.08-0.07-0.35-0.26
90 days ago-0.08-0.07-0.35-0.26
EPS revisionsCurrent qtr. (Apr 2024)Next qtr. (Jul 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesIPAIndustrySector(s)S&P 500
Current qtr.50.00%N/AN/AN/A
Next qtr.30.00%N/AN/AN/A
Current year57.00%N/AN/AN/A
Next year26.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A